Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
鈥� Differences in absolute, relative risk highlight complexities of analyzing rare events
Latest in Oncology/Hematology
Health news and commentary gathered by 番茄社区app staff
Two-year survival in second line for patients with BRAF/NRAS wild-type tumors
Study raises questions about how to assess patient risk, experts say
Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers
Study raises questions about how to assess patient risk, experts say
Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers
Oncology/Hematology Case Studies
Rare condition can be deadly without early diagnosis and treatment
Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man
Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge
More in Oncology/Hematology
High overall response rate, even though many were ineligible for trial leading to drug's approval
Substantial drops in cancer-specific mortality affirmed in Chinese trial
News, features, and commentary about cancer-related issues
Rates rose after USPSTF recommendation, but increase was uneven
Knowing what to look for can mean the difference between life and death
Health news and commentary gathered by 番茄社区app staff
Small study suggests large benefit for Lu-177 dotatate in intracranial disease
Many patients may prefer a self-collected swab over a speculum
Latest negative results emphasize "critical" aspect of immunotherapy timing
With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation
Health news and commentary gathered by 番茄社区app staff
Trial finds similar complication and recurrence rates with hypofractionated versus standard RT
Numerical advantage in randomized trial, non-randomized study misses noninferiority mark
Health news and commentary gathered by 番茄社区app staff
